PET scan study of lung inflammation in never or current smokers
Part of Infections, Lungs & breathing clinical trials.
This early research study uses special PET scans to look at lung inflammation linked to a target called CCR2. It may help researchers understand inflammation biology and future treatments, using scan results instead of an investigational drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 or older.
- You are either a never-smoker, or a current smoker who smoked at least 10 cigarettes per day for the past month, with at least 100 cigarettes total in the last month.
- You can do about 1 hour of lying still during PET/CT or PET/MR, and follow the breathing instructions during the CT part.
- You have not used illicit drugs or other inhaled drug agents in the past year.
- You do not have known history of heart, lung, liver, or kidney disease, and you do not have diabetes.
- Your BMI is 35 or lower, and you are not pregnant (a urine test may be done).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether a special PET scan can detect a specific inflammation signal (CCR2) in atherosclerosis—fatty plaque buildup in blood vessels. It may help future doctors better see which plaques are more inflamed and potentially more dangerous.
This trial uses a special PET scan to look at head and neck cancer cells before treatment. It may help doctors learn more about your cancer and decide if different treatments could work better for you.
This trial compares a two-step nuclear imaging scan (SPECT/CT) versus a PET/CT scan to see which works better for lung cancer. It may help guide doctors on the most useful imaging approach before you start lung-cancer treatment.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This study tests a special MRI scan that uses a “hyperpolarized” gas to look at how well the lungs are working. It’s likely looking for safe imaging results and clear lung measurements in people without lung disease.
Hear when a new Lung Inflammation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.